Author

Yiming Cai

The University of Texas MD Anderson Cancer CenterORCID 0000-0003-3533-1953Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yiming Cai1 paper · Tufts University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1

Frequent Co-Authors

Haoqiang YingiD· 2 shared Aaron D. OlawoyiniD· 1 shared Ahsan Saleem FarooqiiD· 1 shared Alexander J. LazariD· 1 shared Alexey V. SorokiniD· 1 shared Anand Kamal SinghiD· 1 shared Angela D. BhallaiD· 1 shared Angela K. DeemiD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Haoqiang YingORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 23, 2025

ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue Sarcomas

Ryan A. Denu, Anand Kamal Singh, Yingda Jiang…·Kunal Rai

This study shows ATRX loss in sarcomas correlates with poor outcomes and identifies TEAD inhibition as a potential therapy for ATRX-deficient tumors.

DOI 10.1101/2025.11.23.689992

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCell Reports MedicinePeer-reviewedJul 25, 2025

Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers

Madelaine Skolastika Theardy, Mitsunobu Takeda, Alexey V. Sorokin…·Wantong Yao

This study identifies the YAP1-SDC1 axis as a driver of resistance to mKRAS inhibitors in gastrointestinal cancers and suggests targeting this axis to overcome resistance.

6 citations

humanexperimental assay

𝕏 PostBluesky

BioengineeringFood Research InternationalPeer-reviewedNov 2, 2024

Microbial lysates as low-cost serum replacements in cellular agriculture media formulation

James Dolgin, Damayanti Chakravarty, Sean F. Sullivan…·Nikhil U. Nair

This study identifies microbial lysates as a low-cost alternative to fetal bovine serum for cultivating meat cells in vitro.

22 citationstop 3%

proteomicsexperimental assay

𝕏 PostBluesky